Blog

RSS Feed
Posted by Michael Wonder on 29 Jun 2020

Successful Eloctaq bid should widen access to the drug in the UK

29 June 2020 - The NHS and Sobi UK have come to an agreement that will give people living with ...

Read more →
Posted by Michael Wonder on 21 Apr 2020

Andexanet alfa for reversing anticoagulation

21 April 2020 - The Department of Health and Social Care has asked NICE to produce guidance on using andexanet alfa ...

Read more →
Posted by Michael Wonder on 27 Sep 2018

Draft NICE decision rejects Respreeza for incurable, genetic disorder

27 September 2018 - NICE has published draft guidelines rejecting NHS use of CSL Behring’s Respreeza for treating emphysema in ...

Read more →